bioAffinity Technologies (BIAF) Stock Chart & Stock Price History $0.25 -0.03 (-10.36%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock bioAffinity Technologies Stock Price Performance The bioAffinity Technologies (BIAF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.90%, with a year-to-date return of -72.42%. In the past month, the stock has decreased 12.48%, reflecting recent market activity. As of the latest close, bioAffinity Technologies traded at $0.28 with a market cap of $7.97 million and volume of 505,263 shares. Receive BIAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-12.85%1 Month Performance-12.48%3 Month Performance+11.56%Year-To-Date Performance-72.42%1 Year Performance-85.90% BIAF Stock Chart for Thursday, August, 14, 2025 BIAF Chart by TradingView bioAffinity Technologies Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025$0.27$0.28+2.23%$0.28$0.26505,263 shs$7.97 million08/12/2025$0.28$0.27-1.83%$0.28$0.27470,713 shs$7.80 million08/11/2025$0.29$0.28-3.12%$0.29$0.27452,223 shs$7.94 million08/08/2025$0.28$0.29+2.89%$0.30$0.28367,985 shs$8.20 million08/07/2025$0.29$0.28-3.42%$0.29$0.27362,388 shs$7.97 million08/06/2025$0.30$0.29-2.75%$0.30$0.28358,868 shs$8.25 million08/05/2025$0.30$0.30-1.94%$0.31$0.27750,304 shs$8.48 million08/04/2025$0.29$0.30+3.51%$0.31$0.29193,345 shs$8.65 million08/01/2025$0.32$0.29-7.38%$0.32$0.28599,829 shs$8.36 million07/31/2025$0.33$0.32-3.27%$0.35$0.31356,149 shs$9.02 million Get the Latest News and Ratings for BIAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025$0.32$0.33+1.30%$0.34$0.32241,657 shs$9.33 million07/29/2025$0.34$0.32-3.72%$0.34$0.31457,259 shs$9.56 million07/28/2025$0.33$0.34+0.60%$0.34$0.33352,174 shs$9.56 million07/25/2025$0.35$0.33-3.77%$0.36$0.33617,546 shs$9.51 million07/24/2025$0.35$0.35-0.17%$0.35$0.33753,867 shs$9.88 million07/23/2025$0.34$0.35+1.37%$0.35$0.331.70 million shs$9.90 million07/22/2025$0.37$0.34-6.03%$0.38$0.331.66 million shs$9.76 million07/21/2025$0.36$0.37+2.13%$0.37$0.351.37 million shs$10.39 million07/18/2025$0.33$0.36+7.68%$0.36$0.331.35 million shs$10.17 million07/17/2025$0.33$0.33+0.58%$0.36$0.301.62 million shs$9.45 million07/16/2025$0.29$0.33+12.67%$0.34$0.292.35 million shs$9.39 million07/15/2025$0.29$0.29+2.13%$0.34$0.2716.73 million shs$8.34 million07/14/2025$0.31$0.29-6.52%$0.31$0.28987,195 shs$8.16 million Related Companies ReShape Lifesciences Stock Chart Data Storage Stock Chart CISO Global Stock Chart Mobiquity Technologies Stock Chart Scienjoy Stock Chart CTRL Group Stock Chart comScore Stock Chart Stran & Company, Inc. Stock Chart AirMedia Group Stock Chart SPAR Group Stock Chart Receive BIAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIAF) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTesla is in troubleThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access